featured
Efficacy of Nemolizumab in Patients With Prurigo Nodularis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis
N. Engl. J. Med 2023 Oct 26;389(17)1579-1589, SG Kwatra, G Yosipovitch, FJ Legat, A Reich, C Paul, D Simon, L Naldi, C Lynde, MS De Bruin-Weller, WK Nahm, M Sauder, R Gharib, S Barbarot, JC Szepietowski, C Conrad, A Fleischer, VT Laquer, L Misery, E Serra-Baldrich, H Lapeere, F Ahmad, ZK Jabbar Lopez, C Piketty, S StänderFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.